Virtual Library

Start Your Search

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer

    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P03 - Early Stage/Localized Disease - Clinical Trials in Progress

    • Type: Posters
    • Track: Early Stage/Localized Disease
    • Presentations: 6
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P03.03 - MERMAID-1: A Phase III Study of Adjuvant Durvalumab plus Chemotherapy in Resected NSCLC Patients with MRD+ Post-Surgery

      00:00 - 00:00  |  Presenter: Solange Peters

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P09 - Health Services Research/Health Economics - Real World Outcomes

    • Type: Posters
    • Track: Health Services Research/Health Economics
    • Presentations: 60
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P09.18 - COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)

      00:00 - 00:00  |  Author(s): Jennifer G. Whisenant

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P83 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Targeted Therapy

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 4
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P83.02 - Niraparib + Pembrolizumab (Pembro) Versus Placebo + Pembro 1L Maintenance Therapy in Advanced NSCLC: ZEAL-1L Phase III Study

      00:00 - 00:00  |  Presenter: Suresh S. Ramalingam

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    IS07 - Industry Symposium Sponsored by Roche: Expert Perspectives on the Management of Lung Cancer

    • Type: Industry Symposium
    • Track:
    • Presentations: 2
    • Coordinates: 1/28/2021, 16:45 - 17:45, Industry Symposia Auditorium (via Industry Hub)
    • +

      IS07.01 - The Past, Present and Future of Biomarker-Driven Advanced NSCLC

      16:45 - 17:15  |  Presenter: Benjamin Solomon

      • Abstract

      No abstract available for this presentation

    • +

      IS07.02 - Future Directions for Cancer Immunotherapy: Resectable NSCLC and Novel Combinations in Lung Cancer

      17:15 - 17:45  |  Presenter: Ross Soo

      • Abstract

      No abstract available for this presentation

  • +

    ES09 - Biomarkers in Immunotherapy

    • Type: Educational Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • Presentations: 8
    • Coordinates: 1/30/2021, 09:15 - 10:15, Scientific Program Auditorium
  • +

    MA06 - Molecular Developments and Novel Treatments in Mesothelioma and Thymoma

    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • Presentations: 13
    • Coordinates: 1/30/2021, 14:15 - 15:15, Scientific Program Auditorium
    • +

      MA06.03 - Phosphorylated Ribosomal Protein S6, Correlation With Characteristics and Clinical Outcome in Patients With MPM: Results from ETOP Mesoscape

      14:15 - 14:20  |  Presenter: Isabelle Opitz

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.